CN Stock MarketDetailed Quotes

600535 Tasly Pharmaceutical Group

Watchlist
  • 13.78
  • +0.21+1.55%
Market Closed Sep 13 15:00 CST
20.59BMarket Cap20.06P/E (TTM)

Tasly Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
18.86%4.46B
33.58%4.36B
42.68%4.45B
138.42%4.32B
75.90%3.75B
35.29%3.26B
35.39%3.12B
-12.10%1.81B
7.45%2.13B
21.00%2.41B
Transactional financial assets
336.87%1.34B
-58.23%498.61M
-73.27%300.71M
-96.05%63.13M
-65.32%305.85M
10.88%1.19B
-24.37%1.12B
537.88%1.6B
15,605.50%882.03M
5,554.04%1.08B
Notes receivable and accounts receivable
19.97%868.39M
9.30%836.13M
-23.23%688M
-8.60%979.71M
-32.33%723.86M
-32.32%764.99M
-30.78%896.21M
-20.64%1.07B
-18.43%1.07B
-29.61%1.13B
-Accounts receivable
19.97%868.39M
9.30%836.13M
-23.23%688M
-8.60%979.71M
-32.33%723.86M
-32.32%764.99M
-30.78%896.21M
-20.64%1.07B
-17.97%1.07B
-29.61%1.13B
Other receivables (including interest and dividends)
-59.77%17.86M
21.17%49.25M
27.91%11.49M
-75.10%23.31M
-60.85%44.39M
-70.01%40.64M
-5.10%8.98M
-63.81%93.59M
-67.54%113.38M
-62.40%135.53M
-Accrued interest receivable
----
----
----
----
----
----
----
--558.91K
--370.56K
----
-Other receivable
-59.77%17.86M
----
27.91%11.49M
----
-60.72%44.39M
----
-5.10%8.98M
----
-67.65%113.01M
----
Advance payment
-0.43%90.6M
13.29%113.48M
-16.02%65.57M
-18.90%103.39M
-5.55%90.99M
16.84%100.17M
25.34%78.08M
-34.90%127.49M
-51.37%96.34M
-42.77%85.73M
Inventories
8.14%1.82B
8.72%1.79B
14.07%1.75B
1.53%1.73B
0.19%1.68B
-0.11%1.65B
-1.02%1.53B
11.38%1.7B
10.81%1.68B
15.09%1.65B
Receivable financing
-52.20%1.15B
-28.59%1.9B
-41.15%1.44B
-10.38%2.22B
-6.78%2.41B
-2.25%2.66B
-1.98%2.45B
-2.15%2.48B
-4.51%2.58B
-15.73%2.72B
Other current assets
-18.10%19.25M
-11.47%23.8M
-47.24%25.85M
-67.54%6.87M
20.75%23.5M
-55.04%26.89M
14.73%49M
-64.99%21.17M
-66.50%19.46M
-4.61%59.8M
Total current assets
8.10%9.76B
-1.29%9.57B
-5.70%8.73B
6.06%9.45B
5.30%9.03B
4.61%9.7B
0.12%9.26B
8.08%8.91B
5.51%8.57B
4.72%9.27B
Non Current assets
Other non-current financial assets
-25.14%558.57M
-13.82%636M
31.56%638.22M
19.97%732.75M
18.69%746.19M
21.79%738.02M
-34.93%485.1M
-38.25%610.79M
-16.00%628.69M
-6.23%605.97M
Long-term equity investment
-9.62%1.38B
-9.46%1.39B
37.95%1.42B
95.70%1.54B
194.13%1.53B
215.16%1.54B
112.18%1.03B
-7.89%786.48M
-37.50%520.53M
-46.27%487.63M
Fixed assets
-4.66%3.27B
----
-4.80%3.39B
----
-3.57%3.43B
----
-3.33%3.56B
----
4.78%3.56B
----
Constru in process
7.87%197.44M
----
49.44%153.87M
----
-9.72%183.03M
----
-38.66%102.96M
----
-61.04%202.74M
----
Intangible assets
-23.37%548.05M
0.34%561.94M
24.86%573.64M
29.43%586.24M
57.34%715.23M
20.61%560.05M
-3.18%459.43M
6.08%452.94M
21.90%454.57M
29.32%464.35M
Development expenditure
26.17%1.55B
26.84%1.49B
28.81%1.45B
12.05%1.42B
2.25%1.23B
0.69%1.17B
-2.00%1.13B
-8.19%1.27B
-10.69%1.2B
-11.12%1.17B
Goodwill
0.00%15.88M
0.00%15.88M
0.00%15.88M
-90.50%15.88M
-90.50%15.88M
-90.50%15.88M
-90.50%15.88M
0.24%167.08M
0.24%167.08M
0.24%167.08M
Long deferred expense
-12.11%17.34M
-18.69%21.21M
-19.13%23.22M
-35.83%17.4M
-36.16%19.72M
-41.17%26.08M
-32.06%28.72M
-64.89%27.11M
-48.96%30.9M
-41.77%44.33M
Deferred tax assets
-11.30%47.46M
-1.29%52.61M
-43.36%50M
-4.40%53.15M
9.70%53.51M
-29.65%53.3M
45.24%88.29M
-19.64%55.6M
-17.72%48.78M
4.00%75.76M
Usufruct assets
1.52%204.44M
9.09%224.15M
2.77%226.6M
-0.56%201.07M
-4.76%201.39M
-5.05%205.47M
-7.27%220.48M
170.10%202.2M
175.42%211.44M
175.03%216.4M
Other non current assets
18.98%49.9M
-62.12%37.35M
-57.74%43.14M
-30.14%50M
-38.96%41.94M
7.95%98.6M
28.12%102.08M
2,296.40%71.57M
1,646.09%68.71M
999.44%91.34M
Total non current assets
-3.95%7.85B
-1.55%7.94B
10.60%7.98B
11.30%8.23B
15.15%8.17B
13.52%8.07B
-1.04%7.22B
-6.50%7.39B
-7.27%7.09B
-6.24%7.11B
Total assets
2.37%17.6B
-1.41%17.52B
1.44%16.71B
8.44%17.68B
9.76%17.2B
8.47%17.77B
-0.39%16.48B
0.94%16.3B
-0.69%15.67B
-0.34%16.38B
Liabilities
Current liabilities
Short term loan
-12.58%823.42M
-29.05%663.37M
291.95%723.05M
156.89%1.22B
187.16%941.89M
96.41%934.97M
3.67%184.48M
166.24%472.99M
89.41%328M
225.31%476.02M
Transactional financial liabilities
----
----
----
----
----
----
----
--40M
--40M
--40M
Notes payable and accounts payable
101.95%1.59B
47.84%1.25B
-35.49%572.73M
-10.18%809.87M
-9.91%787.77M
-27.95%843.39M
21.85%887.77M
39.45%901.66M
29.78%874.41M
62.78%1.17B
-Notes payable
392.48%1.09B
258.18%706.33M
-56.08%128.91M
13.24%316.39M
-14.47%221.93M
-65.69%197.2M
48.33%293.52M
95.80%279.41M
89.25%259.46M
170.84%574.78M
-Accounts payable
-12.00%497.97M
-16.35%540.57M
-25.31%443.82M
-20.69%493.48M
-7.98%565.84M
8.45%646.19M
11.97%594.25M
23.49%622.25M
14.59%614.95M
17.54%595.86M
Contract liabilities
28.90%100.58M
22.36%93.49M
-3.20%89.02M
240.87%78.63M
71.69%78.03M
30.04%76.4M
39.29%91.96M
-11.02%23.07M
38.56%45.45M
191.86%58.75M
Advance receipts
4.04%66.33M
-11.69%64.02M
3.46%66.36M
-14.73%63.76M
-10.06%63.76M
7.78%72.49M
-2.90%64.14M
13.51%74.77M
5.64%70.89M
-1.40%67.26M
Salaries payable
-17.02%63.79M
-37.77%37.21M
-18.70%114.3M
-18.41%90.73M
-9.59%76.88M
2.12%59.79M
13.02%140.6M
83.83%111.2M
66.41%85.03M
85.21%58.55M
Taxs payable
-21.89%89.54M
-33.86%106.24M
-55.19%85.61M
-19.53%99.48M
-23.23%114.63M
-14.22%160.63M
-4.72%191.07M
26.05%123.63M
6.78%149.31M
88.90%187.26M
Other payable (including interest and dividends)
-65.11%68.32M
-26.98%115.97M
253.16%183.91M
170.25%183.62M
252.35%195.83M
71.86%158.82M
8.08%52.07M
-40.65%67.94M
-32.64%55.58M
-12.25%92.41M
-Other payable
-65.11%68.32M
----
253.16%183.91M
----
252.35%195.83M
----
8.08%52.07M
----
-32.64%55.58M
----
Non current liabilities due within one year
43.22%497.12M
3.68%519.15M
-1.59%521.28M
17.75%445.01M
-43.68%347.11M
34.98%500.72M
32.55%529.69M
172.68%377.93M
347.47%616.3M
-76.12%370.95M
Other current liabilities
-9.46%3.71M
669.81%6.44M
144.68%13.3M
345.71%4.3M
141.49%4.1M
-66.27%836.1K
46.00%5.44M
-67.60%965.14K
-58.37%1.7M
0.35%2.48M
Total current liabilities
26.58%3.3B
1.59%2.85B
10.35%2.37B
36.29%2.99B
15.15%2.61B
11.24%2.81B
15.75%2.15B
64.89%2.19B
66.41%2.27B
-8.07%2.52B
Current liabilities
Long term loan
-32.00%1.24B
-23.13%1.44B
2.75%1.41B
28.16%1.72B
133.81%1.82B
119.63%1.87B
33.04%1.38B
13.44%1.34B
-42.43%778.57M
10.19%852.31M
Deferred tax liabilities
-99.38%110.43K
-88.42%2.36M
-99.52%110.48K
-22.91%16.55M
-29.71%17.95M
-20.35%20.35M
-45.77%22.87M
-69.78%21.47M
-32.04%25.54M
13.32%25.55M
Long term deferred income
-6.57%154.96M
-9.49%159.97M
-10.56%159.02M
-16.15%164.26M
-18.84%165.87M
-16.46%176.74M
-17.14%177.79M
-7.57%195.89M
-6.56%204.36M
-7.80%211.56M
Lease liabilities
16.57%64.63M
21.82%85.56M
8.26%81.52M
28.50%67.31M
-8.60%55.45M
-8.72%70.23M
-7.75%75.31M
623.10%52.38M
737.38%60.66M
962.13%76.94M
Total non current liabilities
-29.23%1.46B
-21.15%1.69B
0.15%1.65B
22.09%1.96B
92.65%2.06B
83.41%2.14B
20.35%1.65B
9.36%1.61B
-33.86%1.07B
12.89%1.17B
Total liabilities
1.96%4.76B
-8.24%4.54B
5.92%4.02B
30.29%4.95B
39.99%4.67B
34.05%4.95B
17.71%3.8B
35.74%3.8B
12.00%3.34B
-2.34%3.69B
Shareholders equity
Paid-in capital
-0.38%1.49B
-0.38%1.49B
0.00%1.5B
0.00%1.5B
0.00%1.5B
-0.55%1.5B
-0.86%1.5B
-0.86%1.5B
-0.86%1.5B
-0.31%1.51B
Capital reserve funds
-18.23%863.56M
-35.50%857.85M
-34.22%958.08M
-27.70%967.51M
-21.08%1.06B
-7.30%1.33B
-4.82%1.46B
-42.36%1.34B
-41.03%1.34B
-38.18%1.43B
Surplus reserve funds
7.33%1.64B
7.33%1.64B
7.33%1.64B
7.12%1.53B
7.12%1.53B
7.12%1.53B
7.12%1.53B
9.87%1.42B
9.87%1.42B
9.87%1.42B
Retained profit
4.84%8.46B
4.55%8.59B
5.96%8.29B
5.34%8.4B
2.20%8.07B
-0.34%8.21B
-11.05%7.83B
-0.96%7.97B
4.33%7.9B
11.58%8.24B
Less:Treasury stock
----
----
0.00%105.98M
0.00%105.98M
0.00%105.98M
-41.04%105.98M
-57.82%105.98M
-53.32%105.98M
-50.97%105.98M
-12.78%179.74M
Other composite income
-44.67%75.65M
-14.72%82.84M
-58.41%88M
37.12%119.99M
820.00%136.73M
393.48%97.14M
757.27%211.58M
381.59%87.51M
31.28%-18.99M
-42.51%-33.1M
Shareholders equity without minority interests
2.86%12.53B
0.79%12.66B
-0.35%12.37B
1.55%12.4B
1.23%12.18B
1.33%12.56B
-4.38%12.41B
-5.47%12.21B
-2.98%12.03B
0.88%12.39B
Minority interests
-9.28%311.9M
22.17%318.98M
21.30%321.59M
12.52%319.14M
15.81%343.8M
-11.34%261.09M
-20.28%265.12M
-33.44%283.64M
-24.60%296.87M
-20.36%294.48M
Total shareholder equity
2.53%12.84B
1.23%12.98B
0.10%12.69B
1.79%12.72B
1.59%12.53B
1.04%12.82B
-4.78%12.68B
-6.36%12.5B
-3.64%12.33B
0.26%12.69B
Total liabilityies and equity
2.37%17.6B
-1.41%17.52B
1.44%16.71B
8.44%17.68B
9.76%17.2B
8.47%17.77B
-0.39%16.48B
0.94%16.3B
-0.69%15.67B
-0.34%16.38B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds 18.86%4.46B33.58%4.36B42.68%4.45B138.42%4.32B75.90%3.75B35.29%3.26B35.39%3.12B-12.10%1.81B7.45%2.13B21.00%2.41B
Transactional financial assets 336.87%1.34B-58.23%498.61M-73.27%300.71M-96.05%63.13M-65.32%305.85M10.88%1.19B-24.37%1.12B537.88%1.6B15,605.50%882.03M5,554.04%1.08B
Notes receivable and accounts receivable 19.97%868.39M9.30%836.13M-23.23%688M-8.60%979.71M-32.33%723.86M-32.32%764.99M-30.78%896.21M-20.64%1.07B-18.43%1.07B-29.61%1.13B
-Accounts receivable 19.97%868.39M9.30%836.13M-23.23%688M-8.60%979.71M-32.33%723.86M-32.32%764.99M-30.78%896.21M-20.64%1.07B-17.97%1.07B-29.61%1.13B
Other receivables (including interest and dividends) -59.77%17.86M21.17%49.25M27.91%11.49M-75.10%23.31M-60.85%44.39M-70.01%40.64M-5.10%8.98M-63.81%93.59M-67.54%113.38M-62.40%135.53M
-Accrued interest receivable ------------------------------558.91K--370.56K----
-Other receivable -59.77%17.86M----27.91%11.49M-----60.72%44.39M-----5.10%8.98M-----67.65%113.01M----
Advance payment -0.43%90.6M13.29%113.48M-16.02%65.57M-18.90%103.39M-5.55%90.99M16.84%100.17M25.34%78.08M-34.90%127.49M-51.37%96.34M-42.77%85.73M
Inventories 8.14%1.82B8.72%1.79B14.07%1.75B1.53%1.73B0.19%1.68B-0.11%1.65B-1.02%1.53B11.38%1.7B10.81%1.68B15.09%1.65B
Receivable financing -52.20%1.15B-28.59%1.9B-41.15%1.44B-10.38%2.22B-6.78%2.41B-2.25%2.66B-1.98%2.45B-2.15%2.48B-4.51%2.58B-15.73%2.72B
Other current assets -18.10%19.25M-11.47%23.8M-47.24%25.85M-67.54%6.87M20.75%23.5M-55.04%26.89M14.73%49M-64.99%21.17M-66.50%19.46M-4.61%59.8M
Total current assets 8.10%9.76B-1.29%9.57B-5.70%8.73B6.06%9.45B5.30%9.03B4.61%9.7B0.12%9.26B8.08%8.91B5.51%8.57B4.72%9.27B
Non Current assets
Other non-current financial assets -25.14%558.57M-13.82%636M31.56%638.22M19.97%732.75M18.69%746.19M21.79%738.02M-34.93%485.1M-38.25%610.79M-16.00%628.69M-6.23%605.97M
Long-term equity investment -9.62%1.38B-9.46%1.39B37.95%1.42B95.70%1.54B194.13%1.53B215.16%1.54B112.18%1.03B-7.89%786.48M-37.50%520.53M-46.27%487.63M
Fixed assets -4.66%3.27B-----4.80%3.39B-----3.57%3.43B-----3.33%3.56B----4.78%3.56B----
Constru in process 7.87%197.44M----49.44%153.87M-----9.72%183.03M-----38.66%102.96M-----61.04%202.74M----
Intangible assets -23.37%548.05M0.34%561.94M24.86%573.64M29.43%586.24M57.34%715.23M20.61%560.05M-3.18%459.43M6.08%452.94M21.90%454.57M29.32%464.35M
Development expenditure 26.17%1.55B26.84%1.49B28.81%1.45B12.05%1.42B2.25%1.23B0.69%1.17B-2.00%1.13B-8.19%1.27B-10.69%1.2B-11.12%1.17B
Goodwill 0.00%15.88M0.00%15.88M0.00%15.88M-90.50%15.88M-90.50%15.88M-90.50%15.88M-90.50%15.88M0.24%167.08M0.24%167.08M0.24%167.08M
Long deferred expense -12.11%17.34M-18.69%21.21M-19.13%23.22M-35.83%17.4M-36.16%19.72M-41.17%26.08M-32.06%28.72M-64.89%27.11M-48.96%30.9M-41.77%44.33M
Deferred tax assets -11.30%47.46M-1.29%52.61M-43.36%50M-4.40%53.15M9.70%53.51M-29.65%53.3M45.24%88.29M-19.64%55.6M-17.72%48.78M4.00%75.76M
Usufruct assets 1.52%204.44M9.09%224.15M2.77%226.6M-0.56%201.07M-4.76%201.39M-5.05%205.47M-7.27%220.48M170.10%202.2M175.42%211.44M175.03%216.4M
Other non current assets 18.98%49.9M-62.12%37.35M-57.74%43.14M-30.14%50M-38.96%41.94M7.95%98.6M28.12%102.08M2,296.40%71.57M1,646.09%68.71M999.44%91.34M
Total non current assets -3.95%7.85B-1.55%7.94B10.60%7.98B11.30%8.23B15.15%8.17B13.52%8.07B-1.04%7.22B-6.50%7.39B-7.27%7.09B-6.24%7.11B
Total assets 2.37%17.6B-1.41%17.52B1.44%16.71B8.44%17.68B9.76%17.2B8.47%17.77B-0.39%16.48B0.94%16.3B-0.69%15.67B-0.34%16.38B
Liabilities
Current liabilities
Short term loan -12.58%823.42M-29.05%663.37M291.95%723.05M156.89%1.22B187.16%941.89M96.41%934.97M3.67%184.48M166.24%472.99M89.41%328M225.31%476.02M
Transactional financial liabilities ------------------------------40M--40M--40M
Notes payable and accounts payable 101.95%1.59B47.84%1.25B-35.49%572.73M-10.18%809.87M-9.91%787.77M-27.95%843.39M21.85%887.77M39.45%901.66M29.78%874.41M62.78%1.17B
-Notes payable 392.48%1.09B258.18%706.33M-56.08%128.91M13.24%316.39M-14.47%221.93M-65.69%197.2M48.33%293.52M95.80%279.41M89.25%259.46M170.84%574.78M
-Accounts payable -12.00%497.97M-16.35%540.57M-25.31%443.82M-20.69%493.48M-7.98%565.84M8.45%646.19M11.97%594.25M23.49%622.25M14.59%614.95M17.54%595.86M
Contract liabilities 28.90%100.58M22.36%93.49M-3.20%89.02M240.87%78.63M71.69%78.03M30.04%76.4M39.29%91.96M-11.02%23.07M38.56%45.45M191.86%58.75M
Advance receipts 4.04%66.33M-11.69%64.02M3.46%66.36M-14.73%63.76M-10.06%63.76M7.78%72.49M-2.90%64.14M13.51%74.77M5.64%70.89M-1.40%67.26M
Salaries payable -17.02%63.79M-37.77%37.21M-18.70%114.3M-18.41%90.73M-9.59%76.88M2.12%59.79M13.02%140.6M83.83%111.2M66.41%85.03M85.21%58.55M
Taxs payable -21.89%89.54M-33.86%106.24M-55.19%85.61M-19.53%99.48M-23.23%114.63M-14.22%160.63M-4.72%191.07M26.05%123.63M6.78%149.31M88.90%187.26M
Other payable (including interest and dividends) -65.11%68.32M-26.98%115.97M253.16%183.91M170.25%183.62M252.35%195.83M71.86%158.82M8.08%52.07M-40.65%67.94M-32.64%55.58M-12.25%92.41M
-Other payable -65.11%68.32M----253.16%183.91M----252.35%195.83M----8.08%52.07M-----32.64%55.58M----
Non current liabilities due within one year 43.22%497.12M3.68%519.15M-1.59%521.28M17.75%445.01M-43.68%347.11M34.98%500.72M32.55%529.69M172.68%377.93M347.47%616.3M-76.12%370.95M
Other current liabilities -9.46%3.71M669.81%6.44M144.68%13.3M345.71%4.3M141.49%4.1M-66.27%836.1K46.00%5.44M-67.60%965.14K-58.37%1.7M0.35%2.48M
Total current liabilities 26.58%3.3B1.59%2.85B10.35%2.37B36.29%2.99B15.15%2.61B11.24%2.81B15.75%2.15B64.89%2.19B66.41%2.27B-8.07%2.52B
Current liabilities
Long term loan -32.00%1.24B-23.13%1.44B2.75%1.41B28.16%1.72B133.81%1.82B119.63%1.87B33.04%1.38B13.44%1.34B-42.43%778.57M10.19%852.31M
Deferred tax liabilities -99.38%110.43K-88.42%2.36M-99.52%110.48K-22.91%16.55M-29.71%17.95M-20.35%20.35M-45.77%22.87M-69.78%21.47M-32.04%25.54M13.32%25.55M
Long term deferred income -6.57%154.96M-9.49%159.97M-10.56%159.02M-16.15%164.26M-18.84%165.87M-16.46%176.74M-17.14%177.79M-7.57%195.89M-6.56%204.36M-7.80%211.56M
Lease liabilities 16.57%64.63M21.82%85.56M8.26%81.52M28.50%67.31M-8.60%55.45M-8.72%70.23M-7.75%75.31M623.10%52.38M737.38%60.66M962.13%76.94M
Total non current liabilities -29.23%1.46B-21.15%1.69B0.15%1.65B22.09%1.96B92.65%2.06B83.41%2.14B20.35%1.65B9.36%1.61B-33.86%1.07B12.89%1.17B
Total liabilities 1.96%4.76B-8.24%4.54B5.92%4.02B30.29%4.95B39.99%4.67B34.05%4.95B17.71%3.8B35.74%3.8B12.00%3.34B-2.34%3.69B
Shareholders equity
Paid-in capital -0.38%1.49B-0.38%1.49B0.00%1.5B0.00%1.5B0.00%1.5B-0.55%1.5B-0.86%1.5B-0.86%1.5B-0.86%1.5B-0.31%1.51B
Capital reserve funds -18.23%863.56M-35.50%857.85M-34.22%958.08M-27.70%967.51M-21.08%1.06B-7.30%1.33B-4.82%1.46B-42.36%1.34B-41.03%1.34B-38.18%1.43B
Surplus reserve funds 7.33%1.64B7.33%1.64B7.33%1.64B7.12%1.53B7.12%1.53B7.12%1.53B7.12%1.53B9.87%1.42B9.87%1.42B9.87%1.42B
Retained profit 4.84%8.46B4.55%8.59B5.96%8.29B5.34%8.4B2.20%8.07B-0.34%8.21B-11.05%7.83B-0.96%7.97B4.33%7.9B11.58%8.24B
Less:Treasury stock --------0.00%105.98M0.00%105.98M0.00%105.98M-41.04%105.98M-57.82%105.98M-53.32%105.98M-50.97%105.98M-12.78%179.74M
Other composite income -44.67%75.65M-14.72%82.84M-58.41%88M37.12%119.99M820.00%136.73M393.48%97.14M757.27%211.58M381.59%87.51M31.28%-18.99M-42.51%-33.1M
Shareholders equity without minority interests 2.86%12.53B0.79%12.66B-0.35%12.37B1.55%12.4B1.23%12.18B1.33%12.56B-4.38%12.41B-5.47%12.21B-2.98%12.03B0.88%12.39B
Minority interests -9.28%311.9M22.17%318.98M21.30%321.59M12.52%319.14M15.81%343.8M-11.34%261.09M-20.28%265.12M-33.44%283.64M-24.60%296.87M-20.36%294.48M
Total shareholder equity 2.53%12.84B1.23%12.98B0.10%12.69B1.79%12.72B1.59%12.53B1.04%12.82B-4.78%12.68B-6.36%12.5B-3.64%12.33B0.26%12.69B
Total liabilityies and equity 2.37%17.6B-1.41%17.52B1.44%16.71B8.44%17.68B9.76%17.2B8.47%17.77B-0.39%16.48B0.94%16.3B-0.69%15.67B-0.34%16.38B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data